Tag: 65995-64-4

To be able to identify mobile pathways connected with therapy-resistant intense lymphoma, we generated rituximab-resistant cell lines (RRCL) and discovered that the acquirement of rituximab resistance was connected with a deregulation in glucose metabolism and a rise in the apoptotic threshold resulting in chemotherapy resistance. HKII was needed in the advancement and maintenance of a…